PGE
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
24 Apr 2024
24 Apr 2024
Historique:
received:
22
05
2023
accepted:
26
03
2024
medline:
25
4
2024
pubmed:
25
4
2024
entrez:
24
4
2024
Statut:
aheadofprint
Résumé
Expansion of antigen-experienced CD8
Identifiants
pubmed: 38658764
doi: 10.1038/s41586-024-07352-w
pii: 10.1038/s41586-024-07352-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Krishna, S. et al. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science 370, 1328–1334 (2020).
pubmed: 33303615
pmcid: 8883579
doi: 10.1126/science.abb9847
Codarri Deak, L. et al. PD-1-cis IL-2R agonism yields better effectors from stem-like CD8
pubmed: 36171284
pmcid: 9534752
doi: 10.1038/s41586-022-05192-0
Hashimoto, M. et al. PD-1 combination therapy with IL-2 modifies CD8
pubmed: 36171288
pmcid: 9793890
doi: 10.1038/s41586-022-05257-0
Bonavita, E. et al. Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade. Immunity 53, 1215–1229.e1218 (2020).
pubmed: 33220234
pmcid: 7772804
doi: 10.1016/j.immuni.2020.10.020
Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162, 1257–1270 (2015).
pubmed: 26343581
pmcid: 4597191
doi: 10.1016/j.cell.2015.08.015
Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015).
pubmed: 25838374
pmcid: 6295668
doi: 10.1126/science.aaa4967
Rohaan, M. W. et al. Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma. N. Engl. J. Med. 387, 2113–2125 (2022).
pubmed: 36477031
doi: 10.1056/NEJMoa2210233
Dafni, U. et al. Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis. Ann. Oncol. 30, 1902–1913 (2019).
pubmed: 31566658
doi: 10.1093/annonc/mdz398
Poschke, I. et al. Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma. Oncoimmunology 5, e1240859 (2016).
pubmed: 28123878
pmcid: 5215250
doi: 10.1080/2162402X.2016.1240859
Kristensen, N. P. et al. Neoantigen-reactive CD8
pubmed: 34813506
pmcid: 8759789
doi: 10.1172/JCI150535
Barras, D. et al. Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8
pubmed: 38306416
doi: 10.1126/sciimmunol.adg7995
Chiffelle, J. et al. Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma. Preprint at bioRxiv 10.1101/2023.2007.2021.544585 (2023).
Sreeramkumar, V., Fresno, M. & Cuesta, N. Prostaglandin E2 and T cells: friends or foes? Immunol. Cell Biol. 90, 579–586 (2012).
pubmed: 21946663
doi: 10.1038/icb.2011.75
Lacher, S. B. et al. PGE
Spolski, R., Li, P. & Leonard, W. J. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat. Rev. Immunol. 18, 648–659 (2018).
pubmed: 30089912
doi: 10.1038/s41577-018-0046-y
Noguchi, M. et al. Functional cleavage of the common cytokine receptor gamma chain (γ
pubmed: 9326644
pmcid: 23528
doi: 10.1073/pnas.94.21.11534
Brudvik, K. W. & Tasken, K. Modulation of T cell immune functions by the prostaglandin E
pubmed: 22141738
pmcid: 3417476
doi: 10.1111/j.1476-5381.2011.01800.x
Lone, A. M. et al. Systems approach reveals distinct and shared signaling networks of the four PGE
pubmed: 34609894
doi: 10.1126/scisignal.abc8579
Miyazaki, T. et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266, 1045–1047 (1994).
pubmed: 7973659
doi: 10.1126/science.7973659
Ravnskjaer, K., Madiraju, A. & Montminy, M. Role of the cAMP pathway in glucose and lipid metabolism. Handb. Exp. Pharmacol. 233, 29–49 (2016).
pubmed: 26721678
doi: 10.1007/164_2015_32
Lone, A. M. & Tasken, K. Phosphoproteomics-based characterization of prostaglandin E
pubmed: 33674363
doi: 10.1124/molpharm.120.000170
McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457–495 (2019).
pubmed: 30676822
doi: 10.1146/annurev-immunol-041015-055318
Huang, J. R., Tan, G. M., Li, Y. & Shi, Z. The emerging role of Cables1 in cancer and other diseases. Mol. Pharmacol. 92, 240–245 (2017).
pubmed: 28119482
doi: 10.1124/mol.116.107730
Tan, C. Y. & Hagen, T. Post-translational regulation of mTOR complex 1 in hypoxia and reoxygenation. Cell Signal 25, 1235–1244 (2013).
pubmed: 23416465
doi: 10.1016/j.cellsig.2013.02.012
Lin, Z. et al. The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis. Nat. Commun. 13, 7965 (2022).
pubmed: 36575162
pmcid: 9794750
doi: 10.1038/s41467-022-35707-2
Masid, M., Ataman, M. & Hatzimanikatis, V. Analysis of human metabolism by reducing the complexity of the genome-scale models using redHUMAN. Nat. Commun. 11, 2821 (2020).
pubmed: 32499584
pmcid: 7272419
doi: 10.1038/s41467-020-16549-2
Pandey, V. & Hatzimanikatis, V. Investigating the deregulation of metabolic tasks via minimum network enrichment analysis (MiNEA) as applied to nonalcoholic fatty liver disease using mouse and human omics data. PLoS Comput. Biol. 15, e1006760 (2019).
pubmed: 31002661
pmcid: 6493771
doi: 10.1371/journal.pcbi.1006760
Sanin, D. E. et al. Mitochondrial membrane potential regulates nuclear gene expression in macrophages exposed to prostaglandin E2. Immunity 49, 1021–1033.e1026 (2018).
pubmed: 30566880
pmcid: 7271981
doi: 10.1016/j.immuni.2018.10.011
Yu, Y. R. et al. Disturbed mitochondrial dynamics in CD8
pubmed: 33020660
doi: 10.1038/s41590-020-0793-3
Sukumar, M. et al. Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy. Cell Metab. 23, 63–76 (2016).
pubmed: 26674251
doi: 10.1016/j.cmet.2015.11.002
Suhm, T. et al. Mitochondrial translation efficiency controls cytoplasmic protein homeostasis. Cell Metab. 27, 1309–1322.e1306 (2018).
pubmed: 29754951
doi: 10.1016/j.cmet.2018.04.011
Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 701–703 (2016).
pubmed: 27653602
doi: 10.1016/j.immuni.2016.08.009
Hosios, A. M. et al. mTORC1 regulates a lysosome-dependent adaptive shift in intracellular lipid species. Nat. Metab. 4, 1792–1811 (2022).
pubmed: 36536136
pmcid: 9799240
doi: 10.1038/s42255-022-00706-6
Manzo, T. et al. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells. 217, e20191920 (2020).
Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8
pubmed: 34102100
pmcid: 9273026
doi: 10.1016/j.immuni.2021.05.003
Nguyen, T. B. et al. DGAT1-dependent lipid droplet biogenesis protects mitochondrial function during starvation-induced autophagy. Dev. Cell 42, 9–21.e25 (2017).
pubmed: 28697336
pmcid: 5553613
doi: 10.1016/j.devcel.2017.06.003
Nakagawa, Y. et al. CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα. Sci. Rep. 6, 39182 (2016).
pubmed: 27982131
pmcid: 5159891
doi: 10.1038/srep39182
Qiu, B. et al. HIF2α-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 5, 652–667 (2015).
pubmed: 25829424
pmcid: 4456212
doi: 10.1158/2159-8290.CD-14-1507
Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266–282 (2021).
pubmed: 33495651
pmcid: 8142022
doi: 10.1038/s41580-020-00324-8
Zheng, J. & Conrad, M. The metabolic underpinnings of ferroptosis. Cell Metab. 32, 920–937 (2020).
pubmed: 33217331
doi: 10.1016/j.cmet.2020.10.011
Gebhardt, T., Park, S. L. & Parish, I. A. Stem-like exhausted and memory CD8
pubmed: 37821656
doi: 10.1038/s41568-023-00615-0
Valmori, D. et al. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J. Immunol. 160, 1750–1758 (1998).
pubmed: 9469433
doi: 10.4049/jimmunol.160.4.1750
Villa, M. et al. Prostaglandin E
pubmed: 38200005
pmcid: 10781727
doi: 10.1038/s41467-024-44689-2
Oliveira, G. et al. Phenotype, specificity and avidity of antitumour CD8
pubmed: 34290406
pmcid: 9187974
doi: 10.1038/s41586-021-03704-y
Lowery, F. J. et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science 375, 877–884 (2022).
pubmed: 35113651
pmcid: 8996692
doi: 10.1126/science.abl5447
Thumkeo, D. et al. PGE
pubmed: 35675777
doi: 10.1016/j.celrep.2022.110914
Gannon, P. O. et al. Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment. Cytotherapy 22, 780–791 (2020).
pubmed: 33069566
doi: 10.1016/j.jcyt.2020.07.011
Jiang, J. et al. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proc. Natl Acad. Sci. USA 109, 3149–3154 (2012).
pubmed: 22323596
pmcid: 3286971
doi: 10.1073/pnas.1120195109
Kabashima, K. et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883–893 (2002).
pubmed: 11927615
pmcid: 150928
doi: 10.1172/JCI0214459
Dunsford, L. S., Thoirs, R. H., Rathbone, E. & Patakas, A. in Immuno-Oncology: Cellular and Translational Approaches (ed. Tan, S. L.) 89–101 (Springer, 2020).
Dumauthioz, N. et al. Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity. Cell. Mol. Immunol. 18, 1761–1771 (2021).
pubmed: 32055005
doi: 10.1038/s41423-020-0365-3
Genolet, R. et al. TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs. Cell Rep. Methods 3, 100459 (2023).
pubmed: 37159666
pmcid: 10163020
doi: 10.1016/j.crmeth.2023.100459
Miklosi, A. G. et al. Super-resolution microscopical localization of dopamine receptors 1 and 2 in rat hippocampal synaptosomes. Mol. Neurobiol. 55, 4857–4869 (2018).
pubmed: 28735416
doi: 10.1007/s12035-017-0688-y
Rooney, J. P. et al. PCR based determination of mitochondrial DNA copy number in multiple species. Methods Mol. Biol. 1241, 23–38 (2015).
pubmed: 25308485
pmcid: 4312664
doi: 10.1007/978-1-4939-1875-1_3
Brunk, E. et al. Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat. Biotechnol. 36, 272–281 (2018).
pubmed: 29457794
pmcid: 5840010
doi: 10.1038/nbt.4072
Pandey, V., Hadadi, N. & Hatzimanikatis, V. Enhanced flux prediction by integrating relative expression and relative metabolite abundance into thermodynamically consistent metabolic models. PLoS Comput. Biol. 15, e1007036 (2019).
pubmed: 31083653
pmcid: 6532942
doi: 10.1371/journal.pcbi.1007036
Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388–W396 (2021).
pubmed: 34019663
pmcid: 8265181
doi: 10.1093/nar/gkab382